Impaired neurotransmission in a mouse model of the slow channel congenital myasthenic syndrome is improved by the sympathomimetic drug ephedrine

Documenti analoghi

• A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment.
  di: Webster, R, et al.
  Pubblicazione: (2013)
• Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
  di: Lashley, D, et al.
  Pubblicazione: (2010)
• CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
  di: Lashley, D, et al.
  Pubblicazione: (2009)
• Congenital myasthenic syndromes and the formation of the neuromuscular junction.
  di: Beeson, D, et al.
  Pubblicazione: (2008)
• Congenital myasthenic syndromes and the formation of the neuromuscular junction
  di: Beeson, D, et al.
  Pubblicazione: (2008)